These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 39376478)

  • 21. Impact of adherence to interferons in the treatment of multiple sclerosis: a non-experimental, retrospective, cohort study.
    Steinberg SC; Faris RJ; Chang CF; Chan A; Tankersley MA
    Clin Drug Investig; 2010; 30(2):89-100. PubMed ID: 20067327
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Budget impact analysis of introducing fruquintinib for metastatic colorectal cancer previously treated with fluoropyrimidine-, oxaliplatin-, and irinotecan-based chemotherapy and biologics in the United States from the payer perspective.
    Paly VF; Li S; Khanduri P; Asfaw AA; Zou D; Hernandez L
    J Med Econ; 2024; 27(1):1076-1085. PubMed ID: 39102473
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Budget Impact Analysis of Vibegron for the Treatment of Overactive Bladder in the USA.
    Chen JV; Gahn JC; Nesheim J; Mudd PN
    Pharmacoeconomics; 2022 Oct; 40(10):979-988. PubMed ID: 35881325
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association between dispensing channel and medication adherence among medicare beneficiaries taking medications to treat diabetes, high blood pressure, or high blood cholesterol.
    Iyengar RN; Balagere DS; Henderson RR; LeFrancois AL; Rabbitt RM; Frazee SG
    J Manag Care Spec Pharm; 2014 Aug; 20(8):851-61. PubMed ID: 25062079
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Budgetary Impact of Cabazitaxel Use After Docetaxel Treatment for Metastatic Castration-Resistant Prostate Cancer.
    Flannery K; Drea E; Hudspeth L; Corman S; Gao X; Xue M; Miao R
    J Manag Care Spec Pharm; 2017 Apr; 23(4):416-426. PubMed ID: 28345444
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Topical Testosterone Therapy Adherence and Outcomes Among Men With Primary or Secondary Hypogonadism.
    Grabner M; Hepp Z; Raval A; Tian F; Khera M
    J Sex Med; 2018 Feb; 15(2):148-158. PubMed ID: 29425664
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Assessing the association between medication adherence, as defined in quality measures, and disease-state control, health care utilization, and costs in a retrospective database analysis of Medicare supplemental beneficiaries using statin medications.
    Axon DR; Vaffis S; Chinthammit C; Lott BE; Taylor AM; Pickering M; Black H; Warholak T; Campbell PJ
    J Manag Care Spec Pharm; 2020 Dec; 26(12):1529-1537. PubMed ID: 33251989
    [No Abstract]   [Full Text] [Related]  

  • 28. Impact of provider mailings on medication adherence by Medicare Part D members.
    Borah BJ; Qiu Y; Shah ND; Gleason PP
    Healthc (Amst); 2016 Sep; 4(3):207-16. PubMed ID: 27637828
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of a Combined Value-Based Insurance Design and Medication Therapy Management Program on Diabetes Medication Adherence.
    Peaslee A; Wickizer M; Olson J; Topp R
    J Manag Care Spec Pharm; 2016 Nov; 22(11):1303-1309. PubMed ID: 27783550
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Budget Impact of Adding Ivabradine to Standard of Care in Patients with Chronic Systolic Heart Failure in the United States.
    Borer JS; Kansal AR; Dorman ED; Krotneva S; Zheng Y; Patel HK; Tavazzi L; Komajda M; Ford I; Böhm M; Kielhorn A
    J Manag Care Spec Pharm; 2016 Sep; 22(9):1064-71. PubMed ID: 27579829
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Budget Impact of a Steroid-Eluting Sinus Implant Versus Sinus Surgery for Adult Chronic Sinusitis Patients with Nasal Polyps.
    Ernst FR; Imhoff RJ; DeConde A; Manes RP
    J Manag Care Spec Pharm; 2019 Aug; 25(8):941-950. PubMed ID: 30843454
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of Persistent Medication Adherence and Compliance with Lifestyle Recommendations on Major Cardiovascular Events and One-Year Mortality in Patients with Type 2 Diabetes and Advanced Stages of Atherosclerosis: Results From a Prospective Cohort Study.
    Shalaeva EV; Bano A; Kasimov U; Janabaev B; Laimer M; Saner H
    Glob Heart; 2023; 18(1):61. PubMed ID: 37928361
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Budgetary Impact of Adding Riociguat to a US Health Plan for the Treatment of Patients with Pulmonary Arterial Hypertension or Chronic Thromboembolic Pulmonary Hypertension.
    Burudpakdee C; Shah A; Joish VN; Divers C; Yaldo A
    Am Health Drug Benefits; 2014 Dec; 7(9):479-87. PubMed ID: 25610527
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Real-World Evidence of the Clinical and Economic Impact of Long-Acting Injectable Versus Oral Antipsychotics Among Patients with Schizophrenia in the United States: A Systematic Review and Meta-Analysis.
    Lin D; Thompson-Leduc P; Ghelerter I; Nguyen H; Lafeuille MH; Benson C; Mavros P; Lefebvre P
    CNS Drugs; 2021 May; 35(5):469-481. PubMed ID: 33909272
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effects of oral anticancer parity laws on out-of-pocket spending and adherence among commercially insured patients with chronic myeloid leukemia.
    Spargo A; Yost C; Squires P; Raju A; Schroader B; Brown JD
    J Manag Care Spec Pharm; 2021 May; 27(5):554-564. PubMed ID: 33908275
    [No Abstract]   [Full Text] [Related]  

  • 36. A retrospective cohort study evaluating the relationship between statin medication adherence and economic outcomes in commercial health plans.
    Chinthammit C; Axon DR; Anderson S; Lott B; Taylor AM; Pickering M; Black H; Warholak T; Campbell PJ
    J Clin Lipidol; 2020; 14(6):791-798. PubMed ID: 33011136
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical and economic impact of long-acting injectable antipsychotics in patients previously treated with short-acting oral antipsychotics.
    Kheloussi S; Oberlin J; Trauger M; Testa ND
    J Manag Care Spec Pharm; 2022 Oct; 28(10):1130-1137. PubMed ID: 36125056
    [No Abstract]   [Full Text] [Related]  

  • 38. Evaluating the relationship between quality measure adherence definitions and economic outcomes in commercial health plans: a retrospective diabetes cohort study.
    Chinthammit C; Axon DR; Mollon L; Taylor AM; Pickering M; Black H; Warholak T; Campbell PJ
    J Manag Care Spec Pharm; 2021 Jan; 27(1):64-72. PubMed ID: 33377445
    [No Abstract]   [Full Text] [Related]  

  • 39. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevalence of Low-Cost Generic Program Use in a Nationally Representative Cohort of Privately Insured Adults.
    Pauly NJ; Brown JD
    J Manag Care Spec Pharm; 2015 Dec; 21(12):1162-70. PubMed ID: 26679965
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.